Finance

Beta
Lists
AMRUTANJAN:NSE
Amrutanjan Health Care Ltd
₹562.00
+0.37%
(+2.05) 1D
May 29, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AMRUTANJAN...
Open
₹559.95
High
₹567.00
Low
₹552.00
Mkt. cap
16.24B
Avg. vol.
33.76K
Volume
25.99K
P/E ratio
28.06
52-wk high
₹790.95
52-wk low
₹486.00
EPS
₹20.03
Shares outstanding
29.23M
No. of employees
737
Open
₹559.95
High
₹567.00
Low
₹552.00
Mkt. cap
16.24B
Avg. vol.
33.76K
Volume
25.99K
P/E ratio
28.06
52-wk high
₹790.95
52-wk low
₹486.00
EPS
₹20.03
Shares outstanding
29.23M
No. of employees
737
News stories
From sources across the web
Profile
Amrutanjan Healthcare Limited is an Indian pharmaceutical company headquartered in Chennai, Tamil Nadu, India. It was founded by Kasinadhuni Nageswara Rao in Bombay in 1893. Wikipedia
About Amrutanjan Health Care Ltd
CEO-
Employees737
Founded1893
HeadquartersChennai, Tamil Nadu, India
SectorPharmaceutical industry
Websiteamrutanjan.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
940.46M
1.18B
1.41B
1.50B
Cost of goods sold
493.90M
576.55M
637.94M
735.23M
Cost of revenue
493.90M
576.55M
637.94M
735.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
233.82M
297.00M
374.89M
408.34M
Operating expense
377.39M
450.77M
537.01M
599.14M
Total operating expenses
871.29M
1.03B
1.17B
1.33B
Operating income
69.17M
149.68M
235.44M
163.32M
Other non operating income
44.27M
42.96M
41.20M
47.31M
EBT including unusual items
112.93M
192.15M
263.64M
210.16M
EBT excluding unusual items
112.93M
192.15M
276.16M
210.16M
Income tax expense
29.82M
52.53M
69.12M
48.23M
Effective tax rate
26.40%
27.34%
26.22%
22.95%
Other operating expenses
128.26M
138.19M
145.88M
174.74M
Net income
83.11M
139.62M
194.52M
161.93M
Net profit margin
8.84%
11.86%
13.79%
10.81%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-515.00K
-497.00K
-479.00K
-459.00K
Net interest expenses
-515.00K
-497.00K
-479.00K
-459.00K
Depreciation and amortization charges
15.31M
15.58M
16.24M
16.06M
EBITDA
85.48M
165.12M
248.47M
179.11M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer